In Oceania, drug production, trafficking and consumption remain overwhelmingly a criminal justice issue. However, Australia and New Zealand have moved towards policies that prioritise health to respond to drug use. More recently, New Zealand made the headlines with the adoption of an innovative policy towards new psychoactive substances.
The NZ Drug Foundation and Helen Clark Foundation discuss use patterns and markets in Aotearoa / New Zealand, related harms, current regulations and how to reduce harms through psychosocial, cultural, and pharmacological approaches.
Despite falling conviction rates, police discretion in prosecution is having a disproportionate impact among certain groups, including the Māori people, people with prior convictions and people with substance use problems.
The Common Position seeks to incorporate the perspectives and guide the work of a wide range of NGOs from across Asia-Pacific, to help shape and guide civil society and governmental responses over the coming years.
Experiences of resilience in the face of the challenges imposed on service delivery and clients' health by the COVID-19 pandemic underscore the importance of meaningfully engaging affected communities in responses to adverse events.
Kvamme et al. suggest that a significant proportion of Danish users of cannabis as medicine are motivated by a desire to alleviate their ailments whilst minimising the negative side effects that they associate with legal prescription drugs.